Prescription Value Act - Directs the Director of the Agency for Healthcare Research and Quality to: (1) collect scientific evidence regarding the relative clinical appropriateness and cost-effectiveness of prescription drugs frequently used by Medicare and Medicaid beneficiaries; (2) assess the validity and reliability of such evidence; and (3) identify areas of additional research needed to make an objective determination on the clinical appropriateness and cost-effectiveness of such drugs.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.